An official website of the United States government
Home
Name
Roscovitine
Alternate Names
CYC202
R-roscovitine
Seliciclib
Abbreviations
None
Category
Chemotherapy
Subcategory
CDK inhibitor- see remarks
NSC Number
None
Primary Site
Histology
None
Remarks
As of March 2012, roscovitine is currently in clinical trials for NSCLC, AML and B-cell lymphomas. Code in "Other Treatment" until approval received from FDA.
Coding
This drug should be coded
